文献速递炎症性肠病消化内镜

克罗恩病完全内镜愈合比部分内镜愈合与更好的结局相关

Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease.
PubMed 文献 · Clin Gastroenterol Hepatol · 2019-11-16

这项回顾性研究纳入84例接受生物制剂治疗的克罗恩病(CD)且达到黏膜愈合(MH)的患者,比较内镜评分CDEIS为0与CDEIS>0但<4者的长期结局。

要点

  • CDEIS=0的完全内镜愈合者治疗失败率25%,低于部分愈合者的48%。
  • CDEIS=0组无肠切除,部分愈合组肠切除率11%。
  • CDEIS>0但<4是治疗失败的独立相关因素(HR=2.6)。

核心结论

  • 在克罗恩病生物治疗患者中,完全内镜愈合(CDEIS=0)较部分内镜愈合(CDEIS>0但<4)与更低的治疗失败、肠切除和住院风险相关。

研究设计与样本

  • 法国2家大学医院的回顾性研究,纳入2008至2015年接受生物制剂治疗(80%为英夫利西单抗)且达到黏膜愈合的84例克罗恩病患者,随访至治疗失败或2016年6月。

主要发现

  • 中位随访4.8年(IQR 2.1-7.2)时,27例(32%)出现治疗失败,3例(3.6%)接受肠切除。

临床怎么用

  • 对达到内镜愈合的克罗恩病患者,可进一步以CDEIS=0作为更优的长期结局参考指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Mucosal healing (MH) has been associated with good outcomes of patients with Crohn's disease (CD). It is not clear what levels of endoscopic healing, based on CD endoscopic index score (CDEIS), associate with different courses of disease progression. We assessed long-term outcomes of patients with CD according to different levels of MH. METHODS: We performed a retrospective study of 84 patients with CD and MH who received biologic therapy (80% with infliximab) from 2008 through 2015 at 2 university hospitals in France and compared outcomes of patients with CD endoscopic index scores (CDEISs) of 0 vs CDEISs greater than 0 but less than 4. Patients were followed until treatment failure or through June 2016. The primary outcome measure was treatment failure, defined by the need for biologic optimization, initiation of corticosteroids, or a Harvey-Bradshaw score above 4 associated with change in treatment, CD-related hospitalization, and/or intestinal resection. RESULTS: After a median follow-up time of 4.8 years (interquartile range, 2.1-7.2), 27 patients (32%) had treatment failure and 3 patients (3.6%) underwent an intestinal resection. Rates of treatment failure were 25% in patients with a CDEIS of 0 and 48% in patients with CDEISs greater than 0 but less than 4 (P = .045). Median times to treatment failure were 21 months (interquartile range, 5-43 months) in patients with a CDEIS of 0 and 13 months (interquartile range, 3.6-35 months) in patients with CDEISs greater than 0 but less than 4 (P = .047). None of the patients with a CEDIS of 0 underwent intestinal resection whereas 11% patients with CDEISs greater than 0 but less than 4 required intestinal resection (P = .031). Patients with a CDEIS of 0 also had a significant lower rate of CD-related hospitalizations than patients with CDEISs greater than 0 but less than 4 (3.5% vs 18%; P = .013). In multivariate analysis, CDEISs greater than 0 but less than 4 (vs CDEIS = 0) was the only factor associated with treatment failure (hazard ratio, 2.6; 95% CI, 1.2-5.8; P = .02). CONCLUSIONS: Complete endoscopic healing (CDEIS = 0) is associated with better long-term outcomes than partial endoscopic healing (CDEIS = 1-4) in patients with CD, as well as fewer surgeries and hospitalizations and an overall decreased risk of treatment failure.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Yzet C, Diouf M, Le Mouel JP, et al. Complete Endoscopic Healing Associated With Better Outcomes Than Partial Endoscopic Healing in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2019. PMID: 31743755. doi:10.1016/j.cgh.2019.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。